Disrupt the gene that regulates the biological clocks in mice and they become manic, exhibiting behaviors similar to humans with bipolar disorder, UT Southwestern Medical Center researchers have found.
The parasite that leads to sleeping sickness can be lulled to sleep itself using a newly discovered pathway, according to research published online this week in EMBO reports. Trypanosoma brucei is a parasite that causes sleeping sickness resulting in neurological damage and death.
In a speech at the Chief Executives Club of Boston, Eli Lilly and Company (NYSE: LLY) chairman and chief executive officer, Sidney Taurel, predicted that the coming biomedical revolution will move medicine from its current state of treating symptoms to predicting and preventing diseases.
World diabetes leaders left the Global Changing Diabetes Leadership Forum, which took place in New York City on 13?14 March 2007, with a sense of activism to return home to start changing diabetes.
AstraZeneca announced that its collaboration partner AtheroGenics, Inc. (Nasdaq: AGIX) revealed first results from the ARISE (Aggressive Reduction of Inflammation Stops Events) phase III clinical outcomes trial which studied AGI-1067, an investigational anti-atherosclerotic agent with antioxidant and anti-inflammatory effects, in patients with coronary artery disease (CAD).
“Eat your vegetables” has been heard at the dinner tables of America for a long time. Has the message gotten through? Since 1990 the Dietary Guidelines for Americans has recommended consuming at least two servings of fruits and three servings of vegetables daily. However, two studies published in the April issue of the American Journal of Preventive Medicine clearly show that Americans are not meeting the mark.
Researchers at Glasgow University revealed that a diet rich in fruit juice could cut the risk of Alzheimer’s disease and other diseases.
Reductions in the death rate from homicide, HIV disease, unintentional injuries – and among women, heart disease – have contributed to narrowing the life expectancy gap between blacks and whites in the United States, although substantial inequalities and challenges remain, according to a study in the March 21 issue of JAMA.
The U.S. Food and Drug Administration (FDA) approved Soliris (eculizumab), the first product for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), a rare type of blood disorder that can lead to disability and premature death. Soliris is classified as an Orphan Drug and is a new molecular entity containing an ingredient not previously marketed in the United States.
The amount and formulation of an adult heart drug given to children with congenital heart failure varies widely across the UK, reveals a survey published ahead of print in the Archives of Disease in Childhood.